In the present study, we established an m6A-related lncRNA-based prognostic model (FAM30A, HCP5, LINC00342, LINC00963, MEG3, HCG18, TMEM147-AS1, N4BP2L2-IT2, and TTTY15) which harbored a satisfied accuracy in predicting the OS of patients with AML in an independent manner. This evidence concerns the gene HCP5 and acute myeloid leukemia.